GoodRx Holdings, Inc.
GoodRx Holdings, Inc.
Your view on GDRX
Overview
What the company does, where it operates, and who runs it.
About GoodRx Holdings, Inc.
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Wendy Barnes
- Headquarters
- 2701 Olympic Boulevard, Santa Monica, CA, US
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Wendy Barnes
- Headquarters
- 2701 Olympic Boulevard, Santa Monica, CA, US
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States.
It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies.
The company was incorporated in 2015 and is headquartered in Santa Monica, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for GoodRx Holdings, Inc., and the rating behind it. GDRX last traded at $3.39, 64.3× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for GoodRx Holdings, Inc.. Starting points for GoodRx Holdings, Inc.: P/E 64.3, EPS $0.05, beta 1.60 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for GoodRx Holdings, Inc.. GoodRx Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for GoodRx Holdings, Inc.. Trailing twelve-month EPS for GoodRx Holdings, Inc. stands at $0.05. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for GoodRx Holdings, Inc.. GoodRx Holdings, Inc. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
GoodRx Holdings, Inc. valued side by side against its closest peers. GoodRx Holdings, Inc. is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold GoodRx Holdings, Inc., and how their positions are changing. At a $1.18B market value, institutional positions materially move GoodRx Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by GoodRx Holdings, Inc. executives and directors. Shares of GoodRx Holdings, Inc. have traded between $2.77 and $5.81 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming GoodRx Holdings, Inc.. GoodRx Holdings, Inc. is a $1.18B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming GoodRx Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for GoodRx Holdings, Inc.. Coverage tracks GoodRx Holdings, Inc. within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.